Labiotech.eu

News and Trends 5 Feb 2018

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

ReViral’s candidate RV521 showed its potential for the treatment of respiratory syncytial virus (RSV) infections by reducing viral load and mucus levels. London-based biotech ReViral discovers and develops antiviral drugs, focusing particularly on the treatment of diseases caused by the respiratory syncytial virus (RSV). The biotech’s candidate, RV521, has undergone a Phase IIa clinical trial during […]

February 5, 2018 - 3 minutesmins - By Alex Dale

lig biowise diagnostics antimicrobial resistance

More News! 5 Feb 2018

A DNA-Based Diagnostic Company Rakes in £1.8M to Combat Antimicrobial Resistance

A new molecular diagnostics company, LIG Biowise, has just closed a £1.8M Series A fundraising round in its effort to combat antimicrobial resistance. Based in Manchester, LIG Biowise, is working on a DNA-based diagnostic to catch antibiotic resistant infections early. The company has now closed a Series A of £1.8M (€2.0M), led by Hong Kong-based Phoenix Bridge, to fund […]

February 5, 2018 - 1 minutemin - By Evelyn Warner

Deconstructing patterns exhibition francis crick institute

News and Trends 3 Feb 2018

Deconstructing Patterns: First Science and Art Exhibition Opens at the Francis Crick Institute

Deconstructing patterns, the first exhibition of its kind at the Francis Crick Institute, is the result of months of collaborations between scientists and artists. I got a chance to see it at the opening earlier this week. The new exhibition at the Francis Crick Institute puts into perspective the groundbreaking research happening in the scientists’ […]

February 3, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Feb 2018

The Success Rate of Clinical Trials Is Higher than We Thought

Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trials – which still suggests that it is pretty tough. Clinical trials give us a chance to test how a new drug or therapy interacts with the body and whether it is […]

February 2, 2018 - 3 minutesmins - By Alex Dale

Startup Scout 2 Feb 2018

This French Biotech’s Software Helps Drugs to Succeed in the Clinic

We’re in the French region of Alsace to visit BioNext, which develops software to help pharma and biotech companies to avoid pursuing flawed drug candidates. Mission: So far, BioNext has developed two tools that allow companies developing drugs to take a closer look at the target that they want to manipulate. Target Analysis identifies macromolecules that have specific interaction […]

February 2, 2018 - 1 minutemin - By Alex Dale

News and Trends 1 Feb 2018

3D Printing with Living Cells Could Revolutionize Tissue Engineering

Scientists at the University of Twente have managed to 3D print structures with living cells, which could boost the field of tissue engineering. Researchers at the University of Twente in the Netherlands have used a technique called ‘in-air microfluidics’ to 3D print structures that contain living cells. The work, which was published in Science Advances, allows […]

February 1, 2018 - 3 minutesmins - By Alex Dale

News and Trends 1 Feb 2018

New Diagnostic Tests On the Way as Qiagen Snaps Up a Spanish Biotech

Qiagen will acquire Spanish biotech STAT-Dx for up to €153M – more than 3 times the total funding it has raised so far – to produce fast and effective diagnostic tests for infections and cancer. Molecular diagnostics company Qiagen has agreed to acquire STAT-Dx, a Spanish biotech that focuses on developing tools to provide fast […]

February 1, 2018 - 3 minutesmins - By Alex Dale

cognitive disorders syndesi therapeutics 1

News and Trends 1 Feb 2018

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Syndesi Therapeutics has been formed by UCB and a group of investors, including Novo Seeds and V-Bio to develop a group of compounds for cognitive disorders caused by diseases like Alzheimer’s. Syndesi Therapeutics will use of Belgian biotech UCB’s expertise in drug discovery for neurological conditions to develop new therapies in cognitive disorders using a new […]

February 1, 2018 - 3 minutesmins - By Alex Dale

News and Trends 31 Jan 2018

Your Pee Could Be Used to Build an Artificial Adrenal Gland

Scientists have started generating artificial glands using cells derived from urine, which will allow the study of adrenal disorders that affect growth, development, and metabolism. Researchers at Queen Mary University of London have used cells in urine to begin generating an artificial adrenal gland that could be used to treat adrenal gland disorders. The study, published in Cell Reports, […]

January 31, 2018 - 3 minutesmins - By Alex Dale

News and Trends 31 Jan 2018

Gene Synthesizing Biotech Gets $12M to Boost the Synbio Field

Evonetix has closed a Series A fundraising round to support the development of its gene synthesis platform, an important tool in the emerging synbio field. Evonetix, based in Cambridge, UK, is developing a scalable, high fidelity gene synthesis approach that could be a key tool in the growing synbio field. The biotech has closed a […]

January 31, 2018 - 3 minutesmins - By Alex Dale

In Depth 31 Jan 2018

Why Does Europe Lag Behind the US and China in the Gene Editing Race?

America and China lead the development of new gene editing technologies, producing GMOs and bringing CRISPR-based therapies into the clinic. Could this render European biotechs in this area obsolete? Gene editing technologies have revolutionized genetics and mark a new generation in biomedical and agricultural sciences. There are endless applications for the technology, including gene therapies for […]

January 31, 2018 - 6 minutesmins - By Ekaterina Perets

News and Trends 30 Jan 2018

The Construction of an Industrial Algae Production Plant Begins in Austria

BDI-BioEnergy produces algae for the food, pharma, and cosmetics industries. Now, it will build an industrial production plant to house its technology. BDI-BioEnergy is a specialized plant engineering company based in Styria, Austria. On Saturday, the company signaled the start of the construction of an industrial plant that will use its photobioreactor system to produce algae biomass. […]

January 30, 2018 - 2 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

A DNA-Based Diagnostic Company Rakes in £1.8M to Combat Antimicrobial Resistance

Deconstructing Patterns: First Science and Art Exhibition Opens at the Francis Crick Institute

The Success Rate of Clinical Trials Is Higher than We Thought

This French Biotech’s Software Helps Drugs to Succeed in the Clinic

3D Printing with Living Cells Could Revolutionize Tissue Engineering

New Diagnostic Tests On the Way as Qiagen Snaps Up a Spanish Biotech

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Your Pee Could Be Used to Build an Artificial Adrenal Gland

Gene Synthesizing Biotech Gets $12M to Boost the Synbio Field

Why Does Europe Lag Behind the US and China in the Gene Editing Race?

The Construction of an Industrial Algae Production Plant Begins in Austria

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!